Page last updated: 2024-11-03

procainamide and Coronary Artery Disease

procainamide has been researched along with Coronary Artery Disease in 2 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hahn, M1
Stamer, UM1
Luedi, MM1
Book, M1
Rieder, HU1
Stüber, F1
Otten, RF1
Dusa, AC1
Das, MK1

Other Studies

2 other studies available for procainamide and Coronary Artery Disease

ArticleYear
ASA Status,
    Cells, 2022, 02-22, Volume: 11, Issue:5

    Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain;

2022
Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy.
    Pacing and clinical electrophysiology : PACE, 2007, Volume: 30, Issue:8

    Topics: Anti-Arrhythmia Agents; Atropine; Brugada Syndrome; Cardiotonic Agents; Cholinesterase Inhibitors; C

2007